Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever

Ebola virus (EBOV) is the causative agent of severe hemorrhagic fever in primates, with human case fatality rates up to 90%. Today, there is neither a licensed vaccine nor a treatment available for Ebola hemorrhagic fever (EHF). Single monoclonal antibodies (MAbs) specific for Zaire ebolavirus (ZEBO...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-04, Vol.7 (4), p.e36192-e36192
Hauptverfasser: Marzi, Andrea, Yoshida, Reiko, Miyamoto, Hiroko, Ishijima, Mari, Suzuki, Yasuhiko, Higuchi, Megumi, Matsuyama, Yukie, Igarashi, Manabu, Nakayama, Eri, Kuroda, Makoto, Saijo, Masayuki, Feldmann, Friederike, Brining, Douglas, Feldmann, Heinz, Takada, Ayato
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!